Pre-cessation varenicline treatment vs post-cessation NRT: an uneven playing field.
Jed E. Rose
Abstract
Jed E. Rose
Abstract
The study by Aubin et al 1 published in this issue is significant in that it is the first head-to-head comparison of the two smoking cessation pharmacotherapies: varenicline and nicotine replacement therapy (NRT). The results suggest that varenicline yielded higher rates of smoking abstinence than NRT. However, an important flaw in the design hampers the interpretation of the results. An imbalance resulted from the fact that the varenicline group began treatment …
OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The study by Aubin et al 1 published in this issue is significant in that it is the first head-to-head comparison of the two smoking cessation pharmacotherapies: varenicline and nicotine replacement therapy (NRT). The results suggest that varenicline yielded higher rates of smoking abstinence than NRT. However, an important flaw in the design hampers the interpretation of the results. An imbalance resulted from the fact that the varenicline group began treatment …
Key concepts: Varenicline, Medicine, Smoking cessation, Nicotine replacement therapy, Abstinence, Nicotine, Internal medicine, Psychiatry